期刊文献+

外周血Th17细胞及IL-17^+FoxP3^+T细胞在非小细胞肺癌患者的表达变化 被引量:7

Distribution of peripheral blood T helper 17 cells and IL-17^+FoxP3^+T cells in patients with non-small-cell lung cancer
原文传递
导出
摘要 目的:探讨辅助性T 17(Th17)细胞及白细胞介素17(IL-17)+叉头蛋白3(FoxP3)+T细胞在非小细胞肺癌患者外周血中的表达及意义。方法:57例非小细胞肺癌患者作为研究对象,25名正常人作为对照。采用流式细胞术检测外周血Th17细胞、调节性T细胞(Treg细胞)的百分率以及IL-17+FoxP3+T细胞占Treg细胞的百分率。结果:Ⅳ期非小细胞肺癌患者外周血单核细胞(PBMC)中Th17细胞百分率高于Ⅰ~Ⅲ期患者及正常对照(均P<0.01)。非小细胞肺癌患者PBMC中的Treg细胞百分率高于正常对照,并且IL-17+FoxP3+T细胞占Treg细胞的百分率高于正常对照(P<0.05)。结论:Ⅳ期非小细胞肺癌患者中Th17细胞以及IL-17+FoxP3+T细胞数量增加,Th17以及IL-17+FoxP3+T细胞可能参与了非小细胞肺癌的肿瘤远处转移过程,从而影响肿瘤进程。 Objective To investigate the distribution of T helper 17(Th17) and interleukin-17(IL-17) forkhead box P3(FoxP3)T cells in peripheral blood lymphocytes in patients with non-small cell lung cancer (NSCLC) and its significance. Methods T ceils in peripheral blood of 30 patients with stage 1V and 27 patients with stage I -HI NSCLC were analyzed, and 25 healthy volunteers were served as controls. The percentages of Thl7 cell and regulatory T cell (Treg cell) in peripheral blood and percentage of CD4IL17FoxP3 T cell in Treg cells were determined by flow cytometry. Results The percentage of blood Th17 cell in peripheral blood mononuclear cells (PBMC) was significantly higher in patients with stage 1V NSCLC patients than in stage I -111 NSCLC patients and healthy controls (P〈0.05). The percentage of Treg cell in PBMC and the percentage of CD4IL17FoxP3* T cell in Treg cells were significantly higher in patients with NSCLC than in healthy controls (P〈0.05). Conclusions The percentages of Thl7 cell and CD4+IL17FoxP3 cell were increased in patients with stage 1V NSCLC , which indicated that Thl7 cells and CD4IL17FoxP3 T cells might be involved in distant metastasis of NSCLC and thereby influencing the course of NSCLC. Key words: Non-small cell lung cancer; T helper 17 cells; Regulatory T cells
出处 《内科理论与实践》 2012年第2期110-113,共4页 Journal of Internal Medicine Concepts & Practice
基金 上海自然科学基金基础重点研究项目(项目编号:08JC1415200) 上海市高校选拔培养优秀青年教师科研项目资助(项目编号:jdy09094)
关键词 非小细胞肺癌 辅助性T17细胞 调节性T细胞 Non-small cell lung cancer T helper 17 cells Regulatory T cells
  • 相关文献

参考文献16

  • 1Chen X,Xie Q,Cheng X. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer:enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells[J].Cancer Science,2010,(11):2384-2390.
  • 2Ankathatti Munegowda M,Deng Y,Chibbar R. A distinct role of CD4+ Th17-and Th17-stimulated CD8+CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis[J].Journal of Clinical Immunology,2011,(05):811-826.
  • 3Azzoli CG,Temin S,Aliff T. 2011 focused update of 2009 American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage Ⅳnon-small-cell lung cancer[J].Journal of Clinical Oncology,2011,(28):3825-3831.doi:10.1200/JCO.2010.34.2774.
  • 4He S,Fei M,Wu Y. Distribution and clinical significance of th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients[J].INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2011,(11):7424-7437.
  • 5Kryczek I,Wei S,Zou L. Cutting edge:Thl7 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment[J].Journal of Immunology,2007,(11):6730-6733.
  • 6Zhang B,Rong G,Wei H. The prevalence of Th17cells in patients with gastric cancer[J].Biochemical and Biophysical Research Communications,2008,(03):533-537.doi:10.1016/j.bbrc.2008.07.060.
  • 7Kryczek I,Wei S,Zou L. Cutting edge:Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment[J].Journal of Immunology,2007,(11):6730-6733.
  • 8Zhang JP,Yan J,Xu J. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients[J].Journal of Hepatology,2009,(05):980-989.doi:10.1016/j.jhep.2008.12.033.
  • 9O'Shea JJ,Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4 + T cells[J].Science,2010,(5969):1098-1102.
  • 10Beriou G,Costantino CM,Ashley CW. IL-17-producing human peripheral regulatory T cells retain suppressive function[J].Blood,2009,(18):4240-4249.

同被引文献104

  • 1朱海星,周灵,时国朝,王林林,潘丽娜,万欢英.非小细胞肺癌患者外周血调节性T细胞和辅助性T细胞17的平衡表达特征[J].结核病与肺部健康杂志,2013,2(2). 被引量:1
  • 2Harrington IrE, Hatton RD, Mangan PR, et al. Interieukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. NatImmunol,2005,6:1123-1132.
  • 3Veldhoen M, Hocking RJ, Atkins CJ,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity, 2006, 24:179-189.
  • 4Das J, Ren G, Zhang L, et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med,2009,206 : 2407-2416.
  • 5Volpe E, Servant N, Zollinger R,et al. A critical function for transforming growth factor beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T( H)-I 7 responses. Nat Immunol, 2008,9 : 650-657.
  • 6Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF beta are required for differentiation of human T(H)17 cells. Nature, 2008,454 : 350-352.
  • 7Annunziato F, Cosmi L, Santarlasci V,et al. Phenotypic and functional features of human Thl7 cells. J Exp Med, 2007, 204:1849-1861.
  • 8Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol,2010,72:495 516.
  • 9Chen Z, Laurence A, Or Shea JJ. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol, 2007,19 : 400-408.
  • 10Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol, 2009,123 : 1004-1011.

引证文献7

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部